AI heart monitor study for ejection fraction
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Injuries & trauma clinical trials.
This study uses an AI-powered wearable monitor to check how well your heart pumps blood (ejection fraction) from a simple EKG recording. It may help doctors quickly assess heart function without extra tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able and willing to wear a Holter monitor (a small device that records your heart's rhythm).
- You cannot be on a breathing machine, heart pump, or kidney dialysis at the time of the study.
- You cannot have a history of severe skin reactions to the sticky pads used for ECG monitoring.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an AI-powered wearable patch (the COR ECG) to see if it can better track heart and lung health. It may help doctors find problems earlier without needing bulky equipment.
This trial uses an AI tool to analyze your ECG (heart tracing) to detect low pumping function. It may help find hidden heart issues early, especially if you haven't had a recent heart ultrasound.
This trial uses an artificial intelligence system to analyze electrocardiograms (ECGs, which are recordings of your heart's electrical activity) to detect heart failure early. It is for people over 65 who either have symptoms that might be heart failure or have risk factors for heart failure but no current symptoms.
This trial tests whether a simple home electrocardiogram (ECG) can be used to check your heart function. It may help find people who have a weak heart pump without needing a full heart ultrasound right away.
This study uses an artificial intelligence (AI) program to read your ECG (a heart tracing) and detect early signs of heart failure, high blood pressure in the lungs, or valve disease before you have symptoms. The goal is to see if AI can catch these problems early.
This trial tests an AI system that uses wearable devices and mini-invasive tools to monitor people with chronic heart failure. The goal is to detect changes early and help manage the condition at home.
Hear when a new LV Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.